Carbidopa is a pharmaceutical raw material used in the manufacture of medications for neurological disorders. It acts as a peripheral decarboxylase inhibitor that prevents the metabolism of levodopa before it reaches the brain.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1426847-87-1
(S)-(−)-carbidopa
pharmaceutical raw material
(S)-(−)-carbidopa monohydrate
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
Cinacalcet Related Compound C
pharmaceutical raw material
Xipamide
pharmaceutical raw material
1-(4-((4-((1,2,4)triazolo(1,5-a)pyrid-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-yl)thiourea
pharmaceutical raw material
(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid
TZFNLOMSOLWIDK-JTQLQIEISA-N
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN